These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 132693)

  • 1. Gastrointestinal blood loss on phenylbutazone and feprazone.
    Macfarlane JD; Maisey MN; Grahame R; Burry HC
    Rheumatol Rehabil; 1976 May; 15(2):108-11. PubMed ID: 132693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial of feprazone in ankylosing spondylitis.
    Harkness AJ; Burry HC; Grahame R
    Rheumatol Rehabil; 1977 Aug; 16(3):158-61. PubMed ID: 333540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.
    Fletcher MR; Loebl W; Scott JT
    Ann Rheum Dis; 1975 Apr; 34(2):190-4. PubMed ID: 1094965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some studies of feprazone.
    Haslock I; Burkinshaw L; Berry DJ; Donovan B; Wright V
    Rheumatol Rehabil; 1976 May; 15(2):81-6. PubMed ID: 132695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miscellaneous rheumatological conditions treated in monitored-release studies with feprazone.
    Harris PG
    J Int Med Res; 1981; 9(4):248-52. PubMed ID: 6973494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic injury following feprazone therapy.
    Wiggins J; Scott DL
    Rheumatol Rehabil; 1981 Feb; 20(1):44-5. PubMed ID: 6452677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monitored-release study of methrazone in general practice.
    Harris PG
    J Int Med Res; 1980; 8(4):276-82. PubMed ID: 6447635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia and haemolytic anaemia due to feprazone.
    Bell PM; Humphrey CA
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):17. PubMed ID: 6797620
    [No Abstract]   [Full Text] [Related]  

  • 9. Feprazone compared with indomethacin in the management of rheumatoid arthritis.
    Sturrock R; Isaacs A; Hart FD
    Practitioner; 1975 Jul; 215(1285):94-7. PubMed ID: 1103113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind trial of feprazone in osteoarthritis of the hip.
    Bain LS; Lynch MP; Bruce GM
    Curr Med Res Opin; 1977; 4(9):665-9. PubMed ID: 338255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of feprazone for long-term treatment of rheumatoid arthritis and osteoarthritis.
    Bianchi G; Cerri B; Grasso S; Carazzi R; Dotti F; Ongari R; Cerrato O; Viara M
    Clin Ther; 1981; 3(5):349-55. PubMed ID: 7471130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind trial of feprazone and phenylbutazone in acute gout.
    Reardon JA; Stockman A; Darlington LG; Scott JT
    Curr Med Res Opin; 1980; 6(7):445-8. PubMed ID: 6988172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
    Br Med J; 1978 Jun; 1(6125):1466-7. PubMed ID: 306273
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal failure complicating feprazone treatment.
    Robertson C; Innes S; Paton J
    Hum Toxicol; 1981; 1(1):71-2. PubMed ID: 6217146
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of thermography in the evaluation of the anti-inflammatory activity of feprazone on rheumatoid arthritis.
    Singer F; Gruber J; Graber J; Reinthaler M; Thumb N
    Arzneimittelforschung; 1982; 32(4):427-9. PubMed ID: 7201815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-inflammatory agents in current therapeutics].
    Leynadier F; Perrault M
    Rev Prat; 1975 Jan; 25(5):365-73. PubMed ID: 170661
    [No Abstract]   [Full Text] [Related]  

  • 17. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
    Meloni T; Forteleoni G; Serra M; Daniotti S; Negri L; Giuntini P; Canepa L; Gaetani GF
    J Clin Pharmacol; 1982; 22(8-9):418-20. PubMed ID: 7130431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastro-intestinal blood loss with sustained release aspirin.
    Treadwell BL; Carroll DG; Pomare EW
    N Z Med J; 1973 Nov; 78(503):435-7. PubMed ID: 4544267
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of feprazone in rheumatoid arthritis (author's transl)].
    Shichikawa K; Maeda A; Iwasaki Y
    Ryumachi; 1979 Apr; 19(2):147-63. PubMed ID: 375431
    [No Abstract]   [Full Text] [Related]  

  • 20. Species differences in the metabolism of feprazone, an antiinflammatory drug.
    Gaetani M; Yamaguchi H; Vidi A; Hashimoto Y; Donetti A
    Pharmacol Res Commun; 1979 Sep; 11(8):719-30. PubMed ID: 515116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.